Patient Journey

What is a patient journey?

A patient journey describes how people with a condition actually move through the healthcare system. It captures when patients seek care, which primary care clinicians or specialists they see, how they are tested and diagnosed, when they start treatment, which insurance requirements they face, and whether they continue, switch or stop therapy.

Life sciences companies, providers and payers build patient journey maps to find where patients are lost or delayed. The same condition can have very different journeys by age, insurance type, geography and site of care.

A patient journey is an analytical model, not a clinical pathway. It describes observed patterns and does not recommend how any patient should be treated.

Stages of the patient journey

Most maps include some version of these stages:

• Symptom onset and awareness: when and why a patient first seeks care.
• Diagnosis: tests, referrals between clinicians and the time from first visit to confirmed diagnosis.
• Treatment decision: which therapy is chosen and by which specialty.
• Access: benefits verification, prior authorization, step therapy and out-of-pocket cost.
• Initiation: whether the first prescription is filled or abandoned.
• Adherence and persistence: how consistently and how long the patient stays on therapy, often measured as proportion of days covered (PDC).
• Switching or discontinuation: moves to other therapies, restarts or stopping treatment.

Why the patient journey matters

Journey analysis shows where effort makes the biggest difference. A rare disease with long diagnostic delays points to disease education and referral pathways, while a drug with high prescription abandonment points to access and affordability support. For HCP targeting, journey data shows which specialties diagnose patients and which ones treat them.

Health systems and payers use similar analyses to reduce delays, improve adherence and close gaps in care. Clinical research teams use them to find where eligible patients are seen when selecting trial sites.

Data and privacy limits

Journey analyses are usually built from de-identified longitudinal claims, electronic health record and lab data linked by privacy-preserving tokens. Under HIPAA, health information is de-identified only through the Safe Harbor method, which removes 18 types of identifiers, or through Expert Determination. Each source sees only part of the journey, so a gap in data coverage can look like a gap in care. Patient support programs that use identifiable data typically obtain patient authorization and must avoid offering anything that could be an improper inducement under the Anti-Kickback Statute.